Loading stock data…
Omnicell, Inc. (OMCL)
$40.92+0.79 (+1.97%)
After Hours$41.03+0.11 (+0.27%)· Last close Jun 29
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Omnicell, Inc. in the Healthcare sector is trading at $40.92 with a market capitalization of $1.9B. Wall Street consensus targets $61.29 (7 analysts), implying a +49.8% move over the next 12 months. The stock is currently 26% below its 52-week high of $55.00, remaining 5.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +49.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $309.88M↓ | $313.98M↑ | $310.63M↑ | $290.56M↑ | $269.67M |
| Gross Profit | $140.36M↑ | $130.32M↓ | $134.50M↑ | $127.68M↑ | $110.94M |
| Operating Income | $16.85M↑ | $415,000↓ | $8.24M↑ | $8.12M↑ | -$11.62M |
| Net Income | $11.36M↑ | -$2.03M↓ | $5.46M↓ | $5.64M↑ | -$7.02M |
Peer Comparison
JNJUNHPFE
Fundamentals
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the heal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.91B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
95.20
Beta
Defensive asset. Lower volatility than the S&P 500.
0.96
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.63%
Volume
Today's trading volume
548,996
Recent News
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Do Options Traders Know Something About Omnicell Stock We Don't?
Investors need to pay close attention to OMCL stock based on the movements in the options market lately.
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.